← All Posts
BII
Biogen Inc.
June 10, 2026
•
Author: Phil Ratcliff
•
BIIB
| Item |
Proposal |
Vote |
| 1 |
Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified. |
|
| 1a |
Maria C. Freire |
✓ For(157.354)
|
| 1b |
William A. Hawkins |
✓ For(157.354)
|
| 1c |
Susan K. Langer |
✓ For(157.354)
|
| 1d |
Jesus B. Mantas |
✓ For(157.354)
|
| 1e |
Lloyd Minor |
✓ For(157.354)
|
| 1f |
Menelas Pangalos |
✓ For(157.354)
|
| 1g |
Monish Patolawala |
✓ For(157.354)
|
| 1h |
Eric K. Rowinsky |
✓ For(157.354)
|
| 1i |
Stephen A. Sherwin |
✓ For(157.354)
|
| 1j |
Christopher A. Viehbacher |
Withhold(157.354)
|
| 2 |
To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. |
✓ For(157.354)
|
| 3 |
Say on Pay - To hold an advisory vote on executive compensation. |
✓ For(157.354)
|
| 4 |
The transaction of such other business as may properly come before the meeting. |
Informational(157.354)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.